The Hurdle With Remaining Risk for Hepatocellular Carcinoma in Cirrhotic Patients After a Hepatitis C Cure

Hepatology, Medicine and Policy
doi 10.1186/s41124-016-0019-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Shear Wave Elastography Predicts Hepatocellular Carcinoma Risk in Hepatitis C Patients After Sustained Virological Response

PLoS ONE
Multidisciplinary
2018English

Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection

Hepatology
MedicineHepatology
2016English

Statin and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis

BMC Gastroenterology
MedicineGastroenterology
2020English

Improvement in Thrombocytopenia After Carvedilol Use in Hepatitis C Cirrhotic Patients.

The Professional Medical Journal
2019English

Increased Incidence or Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients Treated With Direct-Acting Antivirals: Myth or Fact?

Expert Review of Anticancer Therapy
OncologyPharmacology
2018English

Laparoscopic Liver Resections for Hepatocellular Carcinoma (HCC) in Cirrhotic Patients

HPB
HepatologyGastroenterology
2004English

Liver Stiffness Measurement in the Risk Assessment of Hepatocellular Carcinoma for Patients With Chronic Hepatitis

Hepatology International
Hepatology
2010English

Development and Surveillance of Hepatocellular Carcinoma in Patients With Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2019English

The Frequency of Occurrence of Hepatocellular Carcinoma After Direct Antiviral Therapy in Hepatitis C Virus Patients

Pakistan Journal of Medical Sciences
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy